#####
Currently, there are 52.17M common shares owned by the public and among those 49.77M shares have been available to trade.
#####
#####
#####
The company’s stock has a 5-day price change of 66.67% and 93.88% over the past three months. CDLX shares are trading -66.15% year to date (YTD), with the 12-month market performance down to -23.18% lower. It has a 12-month low price of $1.22 and touched a high of $9.48 over the same period. CDLX has an average intraday trading volume of 1.00 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 58.07%, 55.85%, and 4.03% respectively.
Institutional ownership of Cardlytics Inc (NASDAQ: CDLX) shares accounts for 54.57% of the company’s 52.17M shares outstanding.
It has a market capitalization of $149.63M and a beta (3y monthly) value of 1.26. The earnings-per-share (ttm) stands at -$3.55. Price movements for the stock have been influenced by the stock’s volatility, which stands at 16.48% over the week and 10.75% over the month.
Earnings per share for the fiscal year are expected to increase by 68.61%, and -5.91% over the next financial year.
#####
Looking at the support for the CDLX, a number of firms have released research notes about the stock. Evercore ISI stated their In-line rating for the stock in a research note on October 11, 2024, with the firm’s price target at $4. Northland Capital coverage for the Cardlytics Inc (CDLX) stock in a research note released on August 16, 2024 offered a Market Perform rating with a price target of $5. Lake Street on their part issued Hold rating on August 08, 2024.
